Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19

At present, global vaccination for the SARS-CoV2 virus 2019 (COVID-19) is 95% effective. Generally, viral infections are arduous to cure due to the mutating nature of viral genomes, with the consequent quick development of resistance, posing significant fatalities or hazards. The novel corona viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Swati Sucharita, Sahoo, Chita Ranjan, Padhy, Rabindra Nath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354522/
https://www.ncbi.nlm.nih.gov/pubmed/34378108
http://dx.doi.org/10.1208/s12249-021-02089-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354522/
https://www.ncbi.nlm.nih.gov/pubmed/34378108
http://dx.doi.org/10.1208/s12249-021-02089-5

Ejemplares similares